STUB1 and neoplasm: As in our discovery cohort (Fig S16), the tumor over blood VAF ratio of CHIP mutations was an independent predictor of shorter overall survival (Fig S21), suggesting that these associations were not solely the result of variations in the burden of CHIP in the blood.